Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
<p><strong>Objective:</strong> To determine persistence of treatment with secukinumab across its different indications.</p><p><strong>Method:</strong> This is a retrospective descriptive observational study including adult patients treated with secukinumab i...
Saved in:
Main Authors: | Elena Conesa-Nicolás (Author), María Henar García-Lagunar (Author), Sara Núñez-Bracamonte (Author), María Sergia García-Simón (Author), María Carmen Mira-Sirvent (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016) -
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
by: Colombo GL, et al.
Published: (2018) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015) -
Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
by: Ploysyne Rattanakaemakorn, et al.
Published: (2024) -
Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
by: Marina Amaral de Ávila Machado, et al.
Published: (2016)